SPS
Susquehanna Portfolio Strategies Portfolio holdings
AUM
$4.58B
This Quarter Return
-0.25%
1 Year Return
+20.83%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$29.7M
AUM Growth
+$29.7M
(-98%)
Cap. Flow
-$1.43B
Cap. Flow
% of AUM
-4,829.82%
Top 10 Holdings %
Top 10 Hldgs %
97.51%
Holding
348
New
–
Increased
–
Reduced
15
Closed
332
Top Buys
No buys this quarter
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$53.3M |
| 2 |
Stryker
SYK
|
$51.4M |
| 3 |
Visa
V
|
$49.1M |
| 4 |
Truist Financial
TFC
|
$39.5M |
| 5 |
Merck
MRK
|
$38.2M |
Sector Composition
| 1 | Materials | 32.35% |
| 2 | Financials | 22.36% |
| 3 | Consumer Discretionary | 16.93% |
| 4 | Technology | 14.53% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Cboe Global Markets
CBOE
$24.3B
| – | – |
-6,800
| Closed | -$1.39M |
|
227
Chemours
CC
$2.29B
| – | – |
-10,492
| Closed | -$213K |
|
228
Ford
F
$46.6B
| – | – |
-1,661,581
| Closed | -$17.5M |
|
229
Agilent Technologies
A
$35.6B
| – | – |
-21,632
| Closed | -$3.21M |
|
230
American Airlines Group
AAL
$8.84B
| – | – |
-633,650
| Closed | -$7.12M |
|
231
Acumen Pharmaceuticals
ABOS
$82.4M
| – | – |
-21,903
| Closed | -$54.3K |
|
232
Adient
ADNT
$1.99B
| – | – |
-62,366
| Closed | -$1.41M |
|
233
Advantage Solutions
ADV
$564M
| – | – |
-11,436
| Closed | -$39.2K |
|
234
AerCap
AER
$22.2B
| – | – |
-192,362
| Closed | -$18.2M |
|
235
Federal Agricultural Mortgage
AGM
$2.26B
| – | – |
-1,981
| Closed | -$371K |
|
236
Albany International
AIN
$1.83B
| – | – |
-4,125
| Closed | -$367K |
|
|
AIV
237
Aimco
AIV
$1.1B
| – | – |
-123,468
| Closed | -$1.12M |
|
238
Alight
ALIT
$2.08B
| – | – |
-208,395
| Closed | -$1.54M |
|
239
Alaska Air
ALK
$7.22B
| – | – |
-173,195
| Closed | -$7.83M |
|
240
Alkermes
ALKS
$4.85B
| – | – |
-42,414
| Closed | -$1.19M |
|
241
Allegion
ALLE
$14.4B
| – | – |
-53,992
| Closed | -$7.87M |
|
242
Ally Financial
ALLY
$12.5B
| – | – |
-15,600
| Closed | -$555K |
|
243
Altimmune
ALT
$331M
| – | – |
-207,197
| Closed | -$1.27M |
|
244
Alto Ingredients
ALTO
$87.5M
| – | – |
-14,599
| Closed | -$23.5K |
|
245
ALX Oncology
ALXO
$55.2M
| – | – |
-26,161
| Closed | -$47.6K |
|
246
Amalgamated Financial
AMAL
$856M
| – | – |
-16,156
| Closed | -$507K |
|
247
American Homes 4 Rent
AMH
$12.9B
| – | – |
-222,356
| Closed | -$8.54M |
|
248
Amkor Technology
AMKR
$5.91B
| – | – |
-49,181
| Closed | -$1.5M |
|
249
A-Mark Precious Metals
AMRK
$580M
| – | – |
-51,191
| Closed | -$2.26M |
|
250
Anika Therapeutics
ANIK
$132M
| – | – |
-30,976
| Closed | -$765K |
|